Gertrude Biomedical
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Gertrude Biomedical is a biotechnology company that develops small-molecule inhibitors targeting transcription factors, such as SOX18, to treat various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gertrude Biomedical Comparables
Compare Gertrude Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reglagene | 82% | |
| Flare Therapeutics | 78% | |
| Kronos Bio | 70% | |
Gertrude Biomedical Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 43% MoM.
- Oct 27, 2024
Monthly visitors grew 60% MoM, reaching 1.6K.
Gertrude Biomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gertrude Biomedical's valuation, stock price, and market status.